Stock A182400 NKMAX CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart NKMAX CO., Ltd.

Equities

A182400

KR7182400002

End-of-day quote Korea S.E.
Other stock markets
 19:00:00 2024-03-24 EDT 		5-day change 1st Jan Change
2,020 KRW +9.54% Intraday chart for NKMAX CO., Ltd. -.--% -67.58%
05-16 NKMAX CO., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-17 NKMAX CO., Ltd. cancelled the transaction announced on October 20, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
NKMAX CO., LTD. Stock NKMAX CO., Ltd.
 125M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 118B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 24.28B -
ARGENX SE Stock argenx SE
 21.96B -
GENMAB A/S Stock Genmab A/S
 18.16B
  1. Stock Market
  2. Equities
  3. A182400 Stock
  4. Charts NKMAX CO., Ltd.
  5. Sector Chart